A randomized double-blind controlled clinical study on the effects of qishen yiqi dropping pills on exercise endurance and quality of life in patients with coronary heart disease after interventional therapy

China-Japan Friendship Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Have a clear understanding of the research content and purpose, participate in the study voluntarily, and sign the informed consent form by himself / herself;
•2. It is consistent with the diagnostic criteria of Western medicine for stable coronary heart disease;
•3. Patients with Qi deficiency and blood stasis syndrome who meet the above diagnostic criteria of TCM;
•4. Complete the overall treatment plan after PCI;
•5. Within 1 week to 6 months after PCI;
•6. The age is between 18 and 75 years old.

•1. There are contraindications of cardiopulmonary exercise test;
•2. Plan for coronary artery bypass grafting or heart transplantation;
•3. Within 3 months before admission: stroke, transient ischemic attack; carotid artery or other major vascular surgery; persistent ventricular tachycardia or ventricular fibrillation;
•4. Ventricular arrhythmia was not controlled effectively (antiarrhythmic drugs or implantable defibrillator were ineffective;
•5. Uncorrected primary obstruction or severe reflux valvular disease, non dilated (restrictive) or hypertrophic cardiomyopathy;
•6. Patients with second or third degree heart block or sick sinus syndrome, without permanent pacemaker, who need implantable devices for heart failure;
•7. Obstructive or bronchospasmodic lung disease (such as asthma, bronchitis, etc.) requires oral or inhaled bronchodilator or hormone therapy;
•8. Pregnant or lactating women and women who plan to become pregnant during the trial period;
•9. Cancer or other systemic diseases, the expected survival time is less than 12 months;
•10. Use other clinical trial drugs or participate in medical device test within 30 days before enrollment;
•11. The researchers considered that they could not participate in the study after clinical evaluation.

发起方

China-Japan Friendship Hospital